Sun Pharma’s arm gets preliminary injunctive relief Prohibiting Biofrontera
Sun Pharmaceutical Industries’ wholly owned subsidiary — DUSA Pharmaceuticals, Inc. has been granted preliminary injunctive relief by a federal district court prohibiting defendants Biofrontera Inc., Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AG from using DUSA’s confidential and proprietary trade secret information. Sun Pharmaceutical Industries (SPIL) is the world’s fourth largest specialty generic pharmaceutical … Read more